Dr. Sandra Anping Tsai, MD

Dr. Tsai practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Tsai's NPI, 1083717359, was assigned on September 5, 2006. Dr. Tsai graduated from UT Southwestern Medical Center in 1995. Dr. Tsai's California license number on file is A65925.

Dr. Tsai's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Tsai's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Tsai is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Tsai to 1 more hospital and 1 home health agency, each named with a free account. Dr. Tsai's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsai practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tsai's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Tsai is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tsai's licenses on file in 2 states: California and Texas.

Dmand AI lists acid reflux, anxiety, atrial fibrillation and flutter, cardiomyopathy, chronic diabetes, chronic hypertension, chronic kidney disease and coronary artery disease among the conditions Dr. Tsai treats.

CMS data shows 423 Medicare services from Dr. Tsai across 6 procedure codes in 2024, for 242 Medicare patients. Medicare paid $24,715 for them.

CMS counts 242 Medicare patients who saw Dr. Tsai in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tsai's median patient age at 60, with 61% women.

In 2024, Dr. Tsai wrote 1,774 Medicare Part D claims for 200 patients. 87% of them were for generic drugs. CMS names the drug for 1,394 of them, across 41 drugs with 11 or more claims each, at $91,702 in total drug cost. In 2023, CMS named 1,411 claims across 44 drugs.

Dr. Tsai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tsai as offering telehealth.

Dmand AI links 16 papers to Dr. Tsai, published from 2015 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Cardiovascular Diseases, Practice Patterns, Physicians' and Primary Health Care. Dr. Tsai has published most often in Clin Diabetes. Dr. Tsai's most frequent co-authors are Eleanor Gwen Levin, MD, Abha Khandelwal, MD and Jennifer Ann Tremmel, MD.

Dmand AI links Dr. Tsai to 1 clinical trial. Conditions studied include Weight Gain and Body Weight Changes.

CMS Open Payments shows 5 general payments to Dr. Tsai from 4 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 62% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $520.

Dmand AI lists 1 award for Dr. Tsai, most recently CMS Stage 1 EHR in 2013.

Dr. Tsai graduated from UT Southwestern Medical Center in 1995.

Dr. Tsai is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.